Remove Clinical Research Remove Compliance Remove Engineering
article thumbnail

Managing Opportunities and Risks in Generative AI Use for Clinical Research

PPD

Generative artificial intelligence (AI) has captured global attention for its transformative potential across industries, and nowhere is the promise greater — or more fraught — than in health care and clinical research. Errors jeopardize patient safety, regulatory compliance and trust. These domains are ripe for innovation.

article thumbnail

Advancing and Safeguarding Clinical Research for a Better Tomorrow

Advarra

Institutional review boards (IRBs) play a crucial role in the ever-evolving field of clinical research. Innovations in fields such as immunotherapy, cancer and chronic diseases owe their existence to clinical trials, which judiciously test and evaluate safety and efficacy.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

IBC vs. IRB: What’s the Difference?

Advarra

Gene therapy research is exciting and full of promise, but because of the risks involved, it’s also highly regulated, requiring an institutional biosafety committee (IBC) to provide additional oversight and risk assessment. IBC membership must include involving two local community members who reside within 50 miles of the research site.

article thumbnail

BioDAOs are Community-Owned Research Translation Engines, Not Investment DAOs

Molecule Blog

In this regard, BioDAOs can be viewed as collaborative research translation engines and a novel form of biotech organization that develops IP through an online-native approach. By fostering a community of stakeholders with aligned incentives and diverse backgrounds, BioDAOs facilitate the translation of technologies.

article thumbnail

Veeva vs Vial | Pros and Cons

Vial

Introduction Veeva Systems and Vial CRO ( contract research organization ) represent stakeholders in the clinical research landscape, which play integral roles in the successful execution of clinical trials.

article thumbnail

Medidata vs. Vial | Pros and Cons

Vial

Vial | Pros and Cons The unprecedented consequences of the COVID-19 pandemic gave rise to the advent of decentralized clinical trials (DCTs), which are studies that use telemedicine and remote or local healthcare professionals to enable participants to join from different locations. billion and now functions as a subsidiary.

article thumbnail

Castor vs. Vial | Pros and Cons

Vial

The team at Vial is a blend of ClinOps (Clinical Operations) expertise and software product and engineering expertise, who have worked together to develop Vial’s technology platform and raise over $100M. The funds have enabled the company to successfully become a leading global, full-service CRO reshaping the future of clinical trials.